z-logo
open-access-imgOpen Access
CD47 regulation of epithelial cell spreading and migration, and its signal transduction
Author(s) -
Shinohara Masahiko,
Ohyama Naoko,
Murata Yoji,
Okazawa Hideki,
Ohnishi Hiroshi,
Ishikawa Osamu,
Matozaki Takashi
Publication year - 2006
Publication title -
cancer science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.035
H-Index - 141
eISSN - 1349-7006
pISSN - 1347-9032
DOI - 10.1111/j.1349-7006.2006.00245.x
Subject(s) - cd47 , microbiology and biotechnology , cell adhesion , biology , cell migration , signal transduction , lamellipodium , protein kinase a , cell , hepatocyte growth factor , mapk/erk pathway , kinase , biochemistry , receptor , phagocytosis
CD47 is an integrin‐associated penta‐transmembrane protein that possesses an immunoglobulin‐like domain in its extracellular region. We have now investigated the role of CD47 in the regulation of epithelial cell spreading and migration. CD47 is colocalized with E‐cadherin at cell–cell adhesion sites of epithelial cells. A Ca 2+ switch experiment showed that CD47 was endocytosed and then relocalized to cell–cell adhesion sites in a similar manner to E‐cadherin. Such polarized localization of CD47 required the multiple spanning region of this protein. Forced expression of CD47 induced cell spreading with marked lamellipodium formation and resulted in both partial disruption of cell–cell adhesion and enhancement of the hepatocyte growth factor‐stimulated scattering of Madin–Darby canine kidney cells. The CD47‐induced cell spreading was blocked by inhibition of Src and mitogen‐activated protein kinase kinase. Thus, these results suggest that CD47 participates in the regulation of cell–cell adhesion and cell migration through reorganization of the actin cytoskeleton in epithelial cells. This function of CD47 is mediated by the activation of Src and mitogen‐activated protein kinase kinase. ( Cancer Sci 2006; 97: 889–895)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here